1.
Clin Infect Dis
; 50(11): 1493-6, 2010 Jun 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20415572
RESUMO
Immunosuppressed patients receiving oseltamivir for 2009 novel H1N1 influenza A infection may develop drug resistance, leading to treatment failure. Intravenous zanamivir was administered on a compassionate-use basis to a profoundly immunosuppressed pediatric patient with severe oseltamivir-resistant novel H1N1 pneumonia. The regimen was well tolerated and was associated with a decrease in viral burden.